Clinical Conversations (C.E.): Recorded Pharmacist Series: Biomarkers 201 — BRCA1 and BRCA2
This episode discusses the Food and Drug Administration and National Institutes of Health Biomarker Working Group updates to the original 2018 BEST Resource in 2021, including the understanding and classification of biomarkers like BRCA1 and BRCA 2. This presentation highlights how these changes affect cancer risk diagnostics and provides a resource for evidence-based application of specific genetic testing in the pharmacist’s clinical practice. CE for this episode expires two years after its original publication date.
The information presented during the podcast reflects solely the opinions…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.